PEPFAR, Zimbabwe will continue to work together, improve country ownership

NewsGuard 100/100 Score

Recognizing World AIDS Day is December 1, U.S. Ambassador to Zimbabwe David Bruce Wharton writes in a Herald opinion piece, "Ending AIDS is a shared responsibility. ... Everyone has a role to play -- government leaders, the private sector, multilateral organizations, civil society, media, faith-based organizations, and each one of us." Noting the U.S. has invested nearly $300 million in the fight against HIV in Zimbabwe since 2000 and plans to contribute $92 million more to the country through PEPFAR over the next year, Wharton says, "Through PEPFAR, the United States is working closely with Zimbabwe to build the country's capacity to lead an effective national response" and increase "country ownership."

"Through strong leadership from the Ministry of Health and Child Welfare and the National AIDS Council and in collaboration with the Global Fund [to Fight AIDS, Tuberculosis and Malaria] and PEPFAR, treatment in Zimbabwe has reached universal access and continues to be rolled out to the benefit of those living with HIV in Zimbabwe," Wharton writes. He concludes, "As we look to the future, the United States remains committed to the global HIV/AIDS response. We will continue to work closely with Zimbabwe and its partners to move towards a long-term response that saves even more lives" (11/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing